Market Cap | ₹56Cr |
ROE | 1.09% |
P/E Ratio(TTM) | -1.70 |
EPS(TTM) | -6.62 |
P/B Ratio | 0.67 |
Dividend Yield | 0.00% |
Industry P/E | 39.88 |
Book Value | 16.71 |
Debt to Equity | 0.03 |
Face Value | 10 |
Parent Organisation | Lasa Supergenerics |
Managing Director | Dr. Omkar Herlekar |
NSE Symbol | LASA |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 105.21 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.98 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.27 | ||
Wockhardt | NA (0.00%) | -154.77 |